Clinical trial
Protein Kinase N1 Level Predicts Acute Kidney Injury in Patients Undergoing Cardiac Surgery
NCT05386940 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protein Kinase N1 Level Predicts Acute Kidney Injury in Patients Undergoing Cardiac Surgery
- Lead sponsor
- Zhongnan Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 22, 2019
- Completion date
- March 14, 2021
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, extracorporeal circulation; complications, surgery